Samsung Debuts New Ultrasound Modality Geared Toward Women's Health and Urology
Combining enhanced imaging capabilities, workflow efficiencies and artificial intelligence (AI)-enabled technology to improve the diagnosis and management of health conditions in women, Samsung has launched the V6 ultrasound system.
Advances in artificial intelligence (AI) technology and image sharing tools with Samsung’s new V6 ultrasound platform may facilitate enhanced workflow efficiencies in the management of women’s health conditions.
Samsung noted that key advances with the V6 ultrasound system include:
• one-click fetal growth measurements with the semi-automated BiometryAssist™ feature;
• AI-enabled uterus measurements to help detect uterine-related abnormalities with UterineAssist™; and
• real-time image sharing between sonographers and referring physicians with the SonoSync™ feature.
The V6 ultrasound platform also features a miniER7 endocavity transducer, which gives clinicians a 180-degree field of view, a frequency range between 2 and 12 MHz, and design enhancements that may enhance patient comfort, according to Samsung.
“The V6 was developed with the clinical needs of women’s health and urology specifically in mind,” said Tracy Bury, a women’s health segment leader for Boston Imaging, the United States headquarters of Samsung’s digital radiography and ultrasound business. “We’re proud to offer a new product that is not only accessible to a broad group of clinicians but also has innovative, automated features that can make patient care simpler and more efficient.”
Study: AI-Generated ADC Maps from MRI More Than Double Specificity in Prostate Cancer Detection
June 5th 2025Emerging research showed that AI-generated ADC mapping from MRI led to significant increases in accuracy, PPV and specificity in comparison to conventional ADC mapping while achieving a 93 percent sensitivity for PCa.
Can AI Assessment of PET Imaging Predict Treatment Outcomes for Patients with Lymphoma?
June 2nd 2025The use of adjunctive AI software with pre-treatment PET imaging demonstrated over a fourfold higher likelihood of predicting progression-free survival (PFS) in patients being treated for lymphoma, according to a new meta-analysis.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
